Sindre Hassfjell
Vermogen: 414 505 $ op 31-05-2026
Vermogen: 414 505 $ op 31-05-2026
Sindre Hassfjell is currently the Chief Technology Officer at Thor Medical ASA. Previously, he worked as the Director-Generator Development at Artbio AS.
He completed his undergraduate and graduate degrees at the University of Oslo in 1996 and 1997, respectively.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
THOR MEDICAL ASA 0,23% | 02-03-2026 | 825.001 ( 0,23% ) | 414 505 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| THOR MEDICAL | Hoofd Techniek/Wetenschap/O&O | 01-06-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Artbio AS
Artbio AS BiotechnologyHealth Technology Operates as a clinical-stage radiopharmaceutical biotechnology business that works to create a new class of alpha radio ligand medicines | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artbio AS
Artbio AS BiotechnologyHealth Technology Operates as a clinical-stage radiopharmaceutical biotechnology business that works to create a new class of alpha radio ligand medicines | Health Technology |
Thor Medical ASA
Thor Medical ASA Miscellaneous Commercial ServicesCommercial Services Produces and supplies alpha particle emitters for cancer therapy | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau